4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-043734
Options or other derivatives
- Chief Commercial Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hoerter Steven L. Chief Commercial Officer | 2018-07-20 | Grant or award · Performance share units | +15,000 | 15,000 | D | ||
Loading xslF345X03/doc4.xml…